AGORA: Advanced Therapy Medicinal Product Good Manufacturing Practice Open Access Research Alliance” , Grant Agreement No. 602366

The AGORA project funding ended in October 2015 but it leaves behind an important legacy. The aim of the project was to address each of the current unmet needs and critical issues arising from our previous FP7 Academic Good Manufacturing Practise (GMP) study on the development and delivery of new advanced therapies for the treatment of cancers and regenerative medicine.

Summary of achievements